Targeting prodromal Alzheimer's disease: too late for prevention?
- PMID: 29097165
- PMCID: PMC5808883
- DOI: 10.1016/S1474-4422(17)30372-1
Targeting prodromal Alzheimer's disease: too late for prevention?
Comment in
-
Alzheimer's disease: evolution of research diagnostic criteria.Lancet Neurol. 2017 Dec;16(12):945. doi: 10.1016/S1474-4422(17)30376-9. Epub 2017 Nov 14. Lancet Neurol. 2017. PMID: 29165249 No abstract available.
Comment on
-
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial.Lancet Neurol. 2017 Dec;16(12):965-975. doi: 10.1016/S1474-4422(17)30332-0. Epub 2017 Oct 30. Lancet Neurol. 2017. PMID: 29097166 Free PMC article. Clinical Trial.
References
-
- Soininen H, Solomon A, Visser PJ, et al. 24-month intervention with a specific multinutrient in people with prodromal Alzheimer’s disease (LipiDiDiet): a randomised, double-blind, controlled trial. Lancet Neurol. 2017 published online Oct 30. http://dx.doi.org/10.1016/S1474-4422(17)30332-0. - DOI - PMC - PubMed
-
- Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6:734–46. - PubMed
-
- Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L, Marzloff G. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res. 2006;1088:83–92. - PubMed
-
- Scheltens P, Kamphuis PJ, Verhey FR, et al. Efficacy of a medical food in mild Alzheimer’s disease: a randomized, controlled trial. Alzheimers Dement. 2010;6:1–10.e1. - PubMed
-
- Scheltens P, Twisk JW, Blesa R, et al. Efficacy of Souvenaid in mild Alzheimer’s disease: results from a randomized, controlled trial. J Alzheimers Dis. 2012;31:225–36. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
